1,055
Views
41
CrossRef citations to date
0
Altmetric
Review

Review: management of Parkinson’s disease

&
Pages 321-340 | Published online: 03 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Diane Connell & John Connell. (2021) ‘Boogieing with Mrs P’: a real-life story, the link between Parkinson’s, music and the dance. Research in Dance Education 22:1, pages 56-72.
Read now
Lesetja J Legoabe, Anél Petzer & Jacobus P Petzer. (2015) 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors. Drug Design, Development and Therapy 9, pages 3635-3644.
Read now

Articles from other publishers (39)

Omar Santiago-Sosa, E. Adriana Camarillo, Sebastián García-Pineda, J. Manuel Solano-Altamirano, Julio M. Hernández-Pérez, Henoc Flores, Juan Rodríguez-Santiago & Raymundo Hernández-Esparza. (2022) Phase change enthalpies of some monosubstituted derivatives of adamantane: an experimental and theoretical study. Structural Chemistry 34:1, pages 193-202.
Crossref
Hai-Yang Wang, Xinqing Hao, Ren Lu, Tao Li, Lanlan Pu, Wei Liu & Zhanhua Liang. (2022) Effects of trihexyphenidyl on prefrontal executive function and spontaneous neural activity in patients with tremor-dominant Parkinson's disease: An fNIRS study. Parkinsonism & Related Disorders 105, pages 96-102.
Crossref
Chukwunonso K. Nwabufo & Omozojie P. Aigbogun. (2022) Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease. Journal of Neurology 269:11, pages 5762-5786.
Crossref
Yajing Wang, Jie Liu, Guoqiang Song, Yingcong Yu & Xianfeng Huang. (2022) Design and Synthesis of PDE2A Inhibitors for the Treatment of Parkinson's Disease. ChemistrySelect 7:36.
Crossref
Letitia Meiring, Jacobus P. Petzer, Lesetja J. Legoabe & Anél Petzer. (2022) The evaluation of N-propargylamine-2-aminotetralin as an inhibitor of monoamine oxidase. Bioorganic & Medicinal Chemistry Letters 67, pages 128746.
Crossref
Ohanube A.K. Goodluck, Obeta M. Uchejeso & Ikeagwulonu R. Chinaza. 2022. Protein Detection. Protein Detection.
Xiumin Liu, Weiwei Liu, Chenkang Wang, Yinzhe Chen, Panwen Liu, Toshihiko Hayashi, Kazunori Mizuno, Shunji Hattori, Hitomi Fujisaki & Takashi Ikejima. (2021) Silibinin attenuates motor dysfunction in a mouse model of Parkinson's disease by suppression of oxidative stress and neuroinflammation along with promotion of mitophagy. Physiology & Behavior 239, pages 113510.
Crossref
Kamalakannan Kaliyan & Anandharaj Ganesan. (2021) Regularization based discriminative feature pattern selection for the classification of Parkinson cases using machine learning. Bio-Algorithms and Med-Systems 17:3, pages 181-189.
Crossref
Li Liu, Yi Chen, Rui-Feng Zeng, Yun Liu, Sai-Sai Xie, Jin-Shuai Lan, Yue Ding, Yi-Ting Yang, Jun Yang & Tong Zhang. (2021) Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson’s disease. Bioorganic Chemistry 109, pages 104685.
Crossref
Harisudha Kuresan, Dhanalakshmi Samiappan, Polu Maneesh Reddy, Remani Sai Mahesh & Kakuru Sriharsha. (2021) WITHDRAWN: Parkinson’s disease analysis using speech signal processing – A research inclination for graduates. Materials Today: Proceedings.
Crossref
René A. J. Crans, Elise Wouters, Marta Valle-León, Jaume Taura, Caio M. Massari, Víctor Fernández-Dueñas, Christophe P. Stove & Francisco Ciruela. (2020) Striatal Dopamine D2-Muscarinic Acetylcholine M1 Receptor–Receptor Interaction in a Model of Movement Disorders. Frontiers in Pharmacology 11.
Crossref
Oleg V. Ardashov, Alla V. Pavlova, Arun Kumar Mahato, Yulia Sidorova, Ekaterina A. Morozova, Dina V. Korchagina, Georgi E. Salnikov, Alexander M. Genaev, Oksana S. Patrusheva, Nikolay S. Li-Zhulanov, Tat’yana G. Tolstikova, Konstantin P. Volcho & Nariman F. Salakhutdinov. (2019) A Novel Small Molecule Supports the Survival of Cultured Dopamine Neurons and May Restore the Dopaminergic Innervation of the Brain in the MPTP Mouse Model of Parkinson’s Disease. ACS Chemical Neuroscience 10:10, pages 4337-4349.
Crossref
M. Luinstra, V. Isufi, L. de Jong, A.W.F. Rutgers, P. Hagedoorn, J. Puttenstein, T. van Laar & H.W. Frijlink. (2019) Learning from Parkinson’s patients: Usability of the Cyclops dry powder inhaler. International Journal of Pharmaceutics 567, pages 118493.
Crossref
Richard L. Jayaraj, Rami Beiram, Sheikh Azimullah, Mohamed Fizur Nagoor Meeran, Shreesh K. Ojha, Abdu Adem & Fakhreya Yousuf Jalal. (2019) Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson’s Disease. Molecules 24:11, pages 2182.
Crossref
Tara Rastgardani, Melissa J. Armstrong, Connie Marras & Anna R. Gagliardi. (2019) Improving patient‐centred care for persons with Parkinson's: Qualitative interviews with care partners about their engagement in discussions of “off” periods. Health Expectations 22:3, pages 555-564.
Crossref
Marianne Luinstra, Wijnand Rutgers, Teus van Laar, Floris Grasmeijer, Anja Begeman, Valmira Isufi, Luc Steenhuis, Paul Hagedoorn, Anne de Boer & Henderik W. Frijlink. (2019) Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson’s disease. Therapeutic Advances in Chronic Disease 10, pages 204062231985761.
Crossref
Ilias Thomas, Mevludin Memedi, Jerker Westin & Dag Nyholm. (2019) The effect of continuous levodopa treatment during the afternoon hours. Acta Neurologica Scandinavica 139:1, pages 70-75.
Crossref
Raja Mehanna, Hubert H. Fernandez, Aparna Wagle Shukla & Jawad A. Bajwa. (2018) Deep Brain Stimulation in Parkinson’s Disease. Parkinson's Disease 2018, pages 1-2.
Crossref
Anzelle Delport, Brian H. Harvey, Anél Petzer & Jacobus P. Petzer. (2017) Methylene blue and its analogues as antidepressant compounds. Metabolic Brain Disease 32:5, pages 1357-1382.
Crossref
Dale B. Schenk, Martin Koller, Daniel K. Ness, Sue G. Griffith, Michael Grundman, Wagner Zago, Jay Soto, George Atiee, Susanne Ostrowitzki & Gene G. Kinney. (2017) First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers. Movement Disorders 32:2, pages 211-218.
Crossref
Raja Mehanna, Jawad A. Bajwa, Hubert Fernandez & Aparna Ashutosh Wagle Shukla. (2017) Cognitive Impact of Deep Brain Stimulation on Parkinson’s Disease Patients. Parkinson's Disease 2017, pages 1-15.
Crossref
Hongxian Pang, Wei Xue, Aixin Shi, Min Li, Yang Li, Guoying Cao, Bei Yan, Fan Dong, Wei Xiao, Guorong He, Guanhua Du, Xin Hu & Gang Cheng. (2016) Multiple-Ascending-Dose Pharmacokinetics and Safety Evaluation of Baicalein Chewable Tablets in Healthy Chinese Volunteers. Clinical Drug Investigation 36:9, pages 713-724.
Crossref
Thomas Friedemann, Yue Ying, Weigang Wang, Edgar R. Kramer, Udo Schumacher, Jian Fei & Sven Schröder. (2016) Neuroprotective Effect of Coptis chinensis in MPP+ and MPTP-Induced Parkinson’s Disease Models . The American Journal of Chinese Medicine 44:05, pages 907-925.
Crossref
Colin Davidson & Fabrizio Schifano. (2016) The potential utility of some legal highs in CNS disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, pages 267-274.
Crossref
Marianne Luinstra, Floris Grasmeijer, Paul Hagedoorn, Jan Reindert Moes, Henderik W. Frijlink & Anne H. de Boer. (2015) A levodopa dry powder inhaler for the treatment of Parkinson’s disease patients in off periods. European Journal of Pharmaceutics and Biopharmaceutics 97, pages 22-29.
Crossref
Lesetja J. Legoabe, Anél Petzer & Jacobus P. Petzer. (2015) The Synthesis and Evaluation of C7-Substituted α -Tetralone Derivatives as Inhibitors of Monoamine Oxidase . Chemical Biology & Drug Design 86:4, pages 895-904.
Crossref
M. Luinstra, A. W. F. Rutgers, H. Dijkstra, F. Grasmeijer, P. Hagedoorn, J. M. J. Vogelzang, H. W. Frijlink & A. H. de Boer. (2015) Can Patients with Parkinson’s Disease Use Dry Powder Inhalers during Off Periods?. PLOS ONE 10:7, pages e0132714.
Crossref
Fei Su, Jiang Wang, Bin Deng & Huiyan Li. (2015) Effects of deep brain stimulation amplitude on the basal-ganglia-thalamo-cortical network. Effects of deep brain stimulation amplitude on the basal-ganglia-thalamo-cortical network.
Idalet Engelbrecht, Jacobus P. Petzer & Anél Petzer. (2015) The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase. Bioorganic & Medicinal Chemistry Letters 25:9, pages 1896-1900.
Crossref
Jan-Peer Elshoff, Willi Cawello, Jens-Otto Andreas, Francois-Xavier Mathy & Marina Braun. (2015) An Update on Pharmacological, Pharmacokinetic Properties and Drug–Drug Interactions of Rotigotine Transdermal System in Parkinson’s Disease and Restless Legs Syndrome. Drugs 75:5, pages 487-501.
Crossref
Samantha R. Summerson, Behnaam Aazhang & Caleb T. Kemere. (2014) Characterizing Motor and Cognitive Effects Associated With Deep Brain Stimulation in the GPi of Hemi-Parkinsonian Rats. IEEE Transactions on Neural Systems and Rehabilitation Engineering 22:6, pages 1218-1227.
Crossref
Min Li, Aixin Shi, Hongxian Pang, Wei Xue, Yang Li, Guoying Cao, Bei Yan, Fan Dong, Kexin Li, Wei Xiao, Guorong He, Guanhua Du & Xin Hu. (2014) Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects. Journal of Ethnopharmacology 156, pages 210-215.
Crossref
Xiaojia Ni, Shaonan Liu, Fuchang Lu, Xiaogeng Shi & Xinfeng Guo. (2014) Efficacy and Safety of Tai Chi for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS ONE 9:6, pages e99377.
Crossref
Joesph Bova & Adam Sergent. (2014) Chiropractic Management of an 81-Year-Old Man With Parkinson Disease Signs and Symptoms. Journal of Chiropractic Medicine 13:2, pages 116-120.
Crossref
Ashley McGill, Sara Houston & Raymond Y.W. Lee. (2014) Dance for Parkinson's: A new framework for research on its physical, mental, emotional, and social benefits. Complementary Therapies in Medicine 22:3, pages 426-432.
Crossref
Xin-Shan Liu, Jin-Feng Li, Shan-Shan Wang, Yu-Tong Wang, Yu-Zhen Zhang, Hong-Lei Yin, Shuang Geng, Hui-Cui Gong, Bing Han & Yun-Liang Wang. (2014) Human Umbilical Cord Mesenchymal Stem Cells Infected with Adenovirus Expressing HGF Promote Regeneration of Damaged Neuron Cells in a Parkinson’s Disease Model . BioMed Research International 2014, pages 1-7.
Crossref
Raja Mehanna & Eugene C Lai. (2013) Deep brain stimulation in Parkinson’s disease. Translational Neurodegeneration 2:1.
Crossref
Sushil Sharma, Carolyn Seungyoun Moon, Azza Khogali, Ali Haidous, Anthony Chabenne, Comfort Ojo, Miriana Jelebinkov, Yousef Kurdi & Manuchair Ebadi. (2013) Biomarkers in Parkinson’s disease (recent update). Neurochemistry International 63:3, pages 201-229.
Crossref
Jin-Feng Li, Hong-Lei Yin, Adam Shuboy, Hai-Feng Duan, Ji-Yu Lou, Jing Li, Hong-wei Wang & Yun-Liang Wang. (2013) Differentiation of hUC-MSC into dopaminergic-like cells after transduction with hepatocyte growth factor. Molecular and Cellular Biochemistry 381:1-2, pages 183-190.
Crossref